Fitusiran
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 71 publications
Non-clotting factor therapies for preventing bleeds in people with congenital hemophilia A or B.
Journal: The Cochrane database of systematic reviews
Published: March 24, 2026
Comparative Efficacy and Safety of Non-Clotting Factor Prophylaxis Versus. on-Demand Therapy in Hemophilia: A Meta-Analysis of Randomized Controlled Trials.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
Published: March 03, 2026
Redefining hemophilia management: treatment goals, nonfactor replacement therapies, and the role of fitusiran.
Journal: The American journal of managed care
Published: January 21, 2026
Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review.
Journal: British journal of pharmacology
Published: January 16, 2026
2025 FDA TIDES (Peptides and Oligonucleotides) Harvest.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: January 12, 2026
Fitusiran: A Novel Antithrombin-Targeting Therapy for Hemophilia A and B, With or Without Inhibitors.
Journal: The Annals of pharmacotherapy
Published: December 26, 2025
Therapeutic Alternatives to Recombinant Biologics: Mechanistic Framework, Clinical Evidence, and Selection Guidance.
Journal: Drug design, development and therapy
Published: December 13, 2025
QFitlia (Fitusiran): redefining hemophilia treatment with RNAi therapy. A correspondence.
Journal: Annals of medicine and surgery (2012)
Published: December 01, 2025
Challenges in Balancing Hemostasis and Thrombosis in Therapy Tailoring for Hemophilia: A Narrative Review.
Journal: International journal of molecular sciences
Published: November 26, 2025
Small RNA or oligonucleotide drugs and challenges in evaluating drug-drug interactions.
Journal: Frontiers in pharmacology
Published: October 07, 2025
Fitusiran (Qfitlia) as a first-in-class RNA interference therapeutic: targeting antithrombin for prophylactic hemostasis in hemophilia.
Journal: Annals of medicine and surgery (2012)
Published: September 29, 2025
Rebalancing therapy for congenital hemophilia
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: July 06, 2025
Last Updated: 04/28/2026